Source:http://linkedlifedata.com/resource/umls/id/C0054835
NCI: An N-sulfo monocyclic beta-lactam antibiotic derived from sulfazecin. Carumonam has high resistance to beta-lactamases and activity against aerobic gram-negative bacteria. It reaches high urinary concentrations and may be used in the treatment of urinary tract infections.